Prognostic implications of serum alpha‐fetoprotein response during treatment of hepatoblastoma

Abstract

Serial monitoring of changes in AFP levels during the treatment, especially perioperative changes, may help identify favorable and poor responders to chemotherapy. Alternative treatment, such as liver transplantation, should be considered for poor responders.